Bokyoung Shin

Bokyoung Shin

Auto-generated profile, based on publicly available information

Bokyoung Shin

Department of Integrative Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2021 in JMIR Mental Health
Verified
Journal Article
Open access
BSBokyoung Shin
Bokyoung Shin
JOJooyoung Oh
Jooyoung Oh
BKByung Moon Kim
Byung Moon Kim
HKHesun Kim
Hesun Kim
HKHyunji Kim
Hyunji Kim
Jae-Jin KimJae-Jin Kim
Jae-Jin Kim
Background: Virtual reality (VR) is as effective a technique as traditional cognitive behavioral therapy (CBT) and a promising tool for treating panic disorder symptoms because VR exposure can be safer and has better acceptability than in vivo exposure and is more immersive than exposure through imagination. CBT techniques can be delivered more effectively using VR as well. So far, VR has required high-quality devices, but the development of mobile VR technology has improved user availability. At the same time, a well-structured form of VR can be reproduced and used anywhere. This means that VR can be used to provide a self-guided form of treatment and address the high treatment costs of evidence-based therapy and the lack of professional therapists. This study aimed to investigate the potential of self-guided VR as an alternative to high-cost treatment. Objective: The main goal of this study was to offer data about the efficacy of a mobile app-based self-led VR CBT in the treatment of panic disorder. Methods: A total of 54 subjects with panic disorder were enrolled in this study and randomly assigned to either the VR treatment group or waitlist group. The VR treatment was designed to be total 12 sessions for 4 weeks. The VR treatment consists of 4 steps in which patients are gradually exposed to phobic stimuli while learning to cope with panic symptoms in each stage. The effectiveness of treatment was assessed through the Panic Disorder Severity Scale, Hamilton Rating Scale for Depression, Body Sensations Questionnaire, Albany Panic and Phobia Questionnaire, Anxiety Sensitivity Index, State-Trait Anxiety Inventory, Hospital Anxiety and Depression Scale, Korean Inventory of Social Avoidance and Distress Scale, Korean Inventory of Depressive Symptomatology, and Perceived Stress Scale. In addition, physiological changes using heart rate variability were evaluated. Results: In within-group analyses, the VR treatment group exhibited improvements in panic disorder symptoms, anxiety, and depression after 4 weeks, while the waitlist group did not show any significant improvement. Compared to the waitlist group, the VR treatment group showed significantly greater improvements in the Panic Disorder Severity Scale in both completer analysis and intention-to-treat analysis. Heart rate variability in the VR treatment group showed improvement in normalized high frequency from baseline to postassessment with no significant differences in any outcome measure between groups. Conclusions: The self-guided, mobile app-based VR intervention was effective in the treatment of panic symptoms and restoring the autonomic nervous system demonstrating the validity of the use of VR for self-guided treatment. VR treatment can be a cost-effective therapeutic approach. Trial Registration: ClinicalTrials.gov NCT04985019; https://clinicaltrials.gov/ct2/show/NCT04985019

9 February 2024 in JMIR Formative Research
Verified
Journal Article
Open access
HLHyerim Lee
Hyerim Lee
ECEung Ho Choi
Eung Ho Choi
JSJung U Shin
Jung U Shin
TKTae-Gyun Kim
Tae-Gyun Kim
JOJooyoung Oh
Jooyoung Oh
MKMeelim Kim
Meelim Kim
Background: User engagement is crucial for digital therapeutics (DTx) effectiveness; due to variations in the conceptualization of engagement and intervention design, assessment and retention of engagement remain challenging. Objective: We investigated the influence of the perceived acceptability of experimental intervention components and satisfaction with core intervention components in DTx on user engagement, while also identifying potential barriers and facilitators to user engagement. Methods: We conducted a mixed methods study with a 2 × 2 factorial design, involving 12 outpatients with atopic dermatitis. Participants were randomized into 4 experimental groups based on push notification (“basic” or “advanced”) and human coach (“on” or “off”) experimental intervention components. All participants engaged in self-monitoring and learning courses as core intervention components within an app-based intervention over 8 weeks. Data were collected through in-app behavioral data, physician- and self-reported questionnaires, and semistructured interviews assessed at baseline, 4 weeks, and 8 weeks. Descriptive statistics and thematic analysis were used to evaluate user engagement, perceived acceptability of experimental intervention components (ie, push notification and human coach), satisfaction with core intervention components (ie, self-monitoring and learning courses), and intervention effectiveness through clinical outcomes. Results: The primary outcome indicated that group 4, provided with “advanced-level push notifications” and a “human coach,” showed higher completion rates for self-monitoring forms and learning courses compared to the predetermined threshold of clinical significance. Qualitative data analysis revealed three key themes: (1) perceived acceptability of the experimental intervention components, (2) satisfaction with the core intervention components, and (3) suggestions for improvement in the overall intervention program. Regarding clinical outcomes, the Perceived Stress Scale and Dermatology Life Quality Index scores presented the highest improvement in group 4. Conclusions: These findings will help refine the intervention and inform the design of a subsequent randomized trial to test its effectiveness. Furthermore, this design may serve as a model for broadly examining and optimizing overall engagement in DTx and for future investigation into the complex relationship between engagement and clinical outcomes. Trial Registration: Clinical Research Information Service KCT0007675; http://tinyurl.com/2m8rjrmv

2 May 2025 in JAACAP Open
Verified
Journal Article
Open access
YCYoon Jae Cho
Yoon Jae Cho
EKEunjoo Kim
Eunjoo Kim
YKYoung-Shin Kim
Young-Shin Kim
HKHosanna H. Kim
Hosanna H. Kim
JKJihyun Kim
Jihyun Kim
BLBennett L. Leventhal
Bennett L. Leventhal
We examine the effect of COVID-19 on South Korean children with autism spectrum disorder (ASD), using a comprehensive online caregiver survey. Caregivers of 132 children were recruited among 292 children identified with ASD in a large general population epidemiologic cohort from a suburban South Korean city. Using the Korean translation of the CoRonavIruS Health Impact Survey, adapted for autism and related neurodevelopmental conditions (CRISIS-AFAR), data were collected at 3 time points (3 months before the pandemic, from January to June of 2021, and 3-4 months after). Changes in adaptive living skills, lower- and higher-order restrictive and repetitive behaviors (RRBs), co-occurring problem behaviors (activity/attention, oppositional, and anxiety/affect) were assessed over time. Characteristics of more vulnerable subgroups were identified. Among 132 children with ASD (81.1% boys, mean 12.6 ± 1.88 years of age), a significantly larger proportion maintained their initial level of adaptive living skills (43.9%), RRBs (39.4%-51.5%), and co-occurring problem behaviors (>75%) when compared with the proportion of children who worsened or fluctuated (p < .001). Less than 25% of the participants showed worsening in any domain from the first to second time point and from the second to third time point. Participants who demonstrated stability in activity/attention problem behaviors and lower-order RRBs had significantly better baseline physical health (p = .032) and higher intelligence, greater ability to attend general education, and milder language deficits (all p = .027). The majority of South Korean children with ASD demonstrated stability despite the lack of consistency or structure during the pandemic. A 2-year longitudinal follow-up study is underway.

21 May 2021 in JMIR Preprints
Verified
Preprint
Open access
BSBokyoung Shin
Bokyoung Shin
JOJooyoung Oh
Jooyoung Oh
BKByung Moon Kim
Byung Moon Kim
HKHesun Kim
Hesun Kim
HKHyunji Kim
Hyunji Kim
Jae-Jin KimJae-Jin Kim
Jae-Jin Kim
BACKGROUND Virtual reality (VR) is as effective a technique as traditional cognitive behavioral therapy (CBT) and a promising tool for treating panic disorder symptoms because VR exposure can be safer and has better acceptability than in vivo exposure and is more immersive than exposure through imagination. CBT techniques can be delivered more effectively using VR as well. So far, VR has required high-quality devices, but the development of mobile VR technology has improved user availability. At the same time, a well-structured form of VR can be reproduced and used anywhere. This means that VR can be used to provide a self-guided form of treatment and address the high treatment costs of evidence-based therapy and the lack of professional therapists. This study aimed to investigate the potential of self-guided VR as an alternative to high-cost treatment. OBJECTIVE The main goal of this study was to offer data about the efficacy of a mobile app-based self-led VR CBT in the treatment of panic disorder. METHODS A total of 54 subjects with panic disorder were enrolled in this study and randomly assigned to either the VR treatment group or waitlist group. The VR treatment was designed to be total 12 sessions for 4 weeks. The VR treatment consists of 4 steps in which patients are gradually exposed to phobic stimuli while learning to cope with panic symptoms in each stage. The effectiveness of treatment was assessed through the Panic Disorder Severity Scale, Hamilton Rating Scale for Depression, Body Sensations Questionnaire, Albany Panic and Phobia Questionnaire, Anxiety Sensitivity Index, State-Trait Anxiety Inventory, Hospital Anxiety and Depression Scale, Korean Inventory of Social Avoidance and Distress Scale, Korean Inventory of Depressive Symptomatology, and Perceived Stress Scale. In addition, physiological changes using heart rate variability were evaluated. RESULTS In within-group analyses, the VR treatment group exhibited improvements in panic disorder symptoms, anxiety, and depression after 4 weeks, while the waitlist group did not show any significant improvement. Compared to the waitlist group, the VR treatment group showed significantly greater improvements in the Panic Disorder Severity Scale in both completer analysis and intention-to-treat analysis. Heart rate variability in the VR treatment group showed improvement in normalized high frequency from baseline to postassessment with no significant differences in any outcome measure between groups. CONCLUSIONS The self-guided, mobile app-based VR intervention was effective in the treatment of panic symptoms and restoring the autonomic nervous system demonstrating the validity of the use of VR for self-guided treatment. VR treatment can be a cost-effective therapeutic approach. CLINICALTRIAL ClinicalTrials.gov NCT04985019; https://clinicaltrials.gov/ct2/show/NCT04985019

25 July 2023 in JMIR Preprints
Verified
Preprint
Open access
HLHyerim Lee
Hyerim Lee
ECEung Ho Choi
Eung Ho Choi
JSJung U Shin
Jung U Shin
TKTae-Gyun Kim
Tae-Gyun Kim
JOJooyoung Oh
Jooyoung Oh
MKMeelim Kim
Meelim Kim
BACKGROUND User engagement is crucial for digital therapeutics (DTx) effectiveness; due to variations in the conceptualization of engagement and intervention design, assessment and retention of engagement remain challenging. OBJECTIVE We investigated the influence of the perceived acceptability of experimental intervention components and satisfaction with core intervention components in DTx on user engagement, while also identifying potential barriers and facilitators to user engagement. METHODS We conducted a mixed methods study with a 2 × 2 factorial design, involving 12 outpatients with atopic dermatitis. Participants were randomized into 4 experimental groups based on push notification (“basic” or “advanced”) and human coach (“on” or “off”) experimental intervention components. All participants engaged in self-monitoring and learning courses as core intervention components within an app-based intervention over 8 weeks. Data were collected through in-app behavioral data, physician- and self-reported questionnaires, and semistructured interviews assessed at baseline, 4 weeks, and 8 weeks. Descriptive statistics and thematic analysis were used to evaluate user engagement, perceived acceptability of experimental intervention components (ie, push notification and human coach), satisfaction with core intervention components (ie, self-monitoring and learning courses), and intervention effectiveness through clinical outcomes. RESULTS The primary outcome indicated that group 4, provided with “advanced-level push notifications” and a “human coach,” showed higher completion rates for self-monitoring forms and learning courses compared to the predetermined threshold of clinical significance. Qualitative data analysis revealed three key themes: (1) perceived acceptability of the experimental intervention components, (2) satisfaction with the core intervention components, and (3) suggestions for improvement in the overall intervention program. Regarding clinical outcomes, the Perceived Stress Scale and Dermatology Life Quality Index scores presented the highest improvement in group 4. CONCLUSIONS These findings will help refine the intervention and inform the design of a subsequent randomized trial to test its effectiveness. Furthermore, this design may serve as a model for broadly examining and optimizing overall engagement in DTx and for future investigation into the complex relationship between engagement and clinical outcomes. CLINICALTRIAL Clinical Research Information Service KCT0007675; http://tinyurl.com/2m8rjrmv